Clinical trials · Nashville, TN
Metastatic Hormone-sensitive Prostate Cancer (mHSPC) clinical trials in Nashville
We’re tracking 4 recruiting metastatic hormone-sensitive prostate cancer (mhspc) studies with a site in or near Nashville — including Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Nashville
- NCT07213674RecruitingPhase 3
A study of xaluritamig plus abiraterone for prostate cancer
This trial tests a new combination of two drugs (xaluritamig plus abiraterone) for men with a type of advanced prostate cancer that is no longer responding to hormone therapy but has not yet been treated with chemotherapy. The goal is to see if this combination works better than the standard options your doctor might choose.
Nashville, TennesseeAges 18 years+ - NCT07493512RecruitingPhase 1
Study of xaluritamig for metastatic prostate cancer
This trial tests a new drug called xaluritamig for men with metastatic prostate cancer that is resistant to hormone therapy. It is designed for those who have already tried certain hormone pills and one type of chemotherapy, and aims to see if the drug can shrink tumors or slow cancer growth.
Nashville, TennesseeAges 18 years+ - NCT04221542RecruitingPhase 1
AMG 509 for advanced, hormone-resistant prostate cancer
This trial tests AMG 509, a study drug, in men with metastatic castration-resistant prostate cancer (cancer that keeps growing despite lowering testosterone). It’s for people whose cancer has progressed after certain hormone tablets and possibly chemotherapy, aiming to shrink tumors and control the disease safely.
Nashville, TennesseeAges 18 years+ - NCT07140900RecruitingPhase 1
Study of xaluritamig combined with hormone therapy for advanced prostate cancer
This trial tests a new drug, xaluritamig, given with standard hormone therapy for men with prostate cancer that has spread to other parts of the body (metastatic) and is still sensitive to hormone therapy. It aims to see if the combination is safe and works better than hormone therapy alone.
Nashville, TennesseeAges 18 years+
Hear when a new Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trial opens near Nashville, TN
We’ll email you when one opens near Nashville, TN — at most once a week, no account needed, unsubscribe anytime.
Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials in other cities
Where these studies are running near Nashville
Institutions with a site for the recruiting metastatic hormone-sensitive prostate cancer (mhspc) studies listed above.
- Sarah Cannon Research Institute · 3 studies
- United States Oncology Regulatory Affairs Corporate Office · 2 studies
What taking part in a metastatic hormone-sensitive prostate cancer (mhspc) study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting metastatic hormone-sensitive prostate cancer (mhspc) studies in Tennessee.
Common questions
- Are there metastatic hormone-sensitive prostate cancer (mhspc) clinical trials near Nashville?
- Yes. We're currently tracking 4 recruiting metastatic hormone-sensitive prostate cancer (mhspc) studies with a site near Nashville, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a metastatic hormone-sensitive prostate cancer (mhspc) study near Nashville?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Nashville to take part?
- Not necessarily. These studies have a site near Nashville, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a metastatic hormone-sensitive prostate cancer (mhspc) trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New metastatic hormone-sensitive prostate cancer (mhspc) studies open near Nashville regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.